Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Patent
1984-11-19
1988-07-26
Marantz, Sidney
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
436501, 436503, 436804, 436815, 540504, G01N 33566, G01N 33567
Patent
active
047600292
ABSTRACT:
A method, reagents, and kit for determining the levels of D-1 receptor antagonistic activity of neuroleptic drugs. The method correlates competition between analyte and tritiated R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol for binding to D-1 receptors in mammalian brain tissue.
REFERENCES:
Billard, W. et al., Life Sciences, 35:1885-1893, (1984).
Hyttel, J., (1983), Eur. Jour. Pharm., 91:153-154.
Billard, W., et al., (1984), Chem. Abstr., vol. 101: abstract No. 184777s.
Barnett Allen
Billard William
Iorio Louis
Billups Richard C.
Marantz Sidney
Miller Stephen I.
Nelson James R.
Schering Corporation
LandOfFree
Assay for D-1 antagonistic activity of neuroleptic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for D-1 antagonistic activity of neuroleptic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for D-1 antagonistic activity of neuroleptic drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-257799